Ramandeep Singh Arora
Overview
Explore the profile of Ramandeep Singh Arora including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
347
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bagai P, Kanwar V, Carnevale F, Macdonald M, Arora R
Indian J Med Ethics
. 2025 Mar;
PMID: 40042080
Background: Childhood cancer has been ranked the most common cause of death due to non-communicable disease among 5- to 14-year-old children in India. Ethical concerns have been identified in the...
2.
Prasad M, Bhatia S, Arora R
Indian Pediatr
. 2024 Apr;
61(4):380-382.
PMID: 38597104
No abstract available.
3.
Kapoor G, Arora R, Radhakrishnan V, Nath A, Malhotra P, Cyriac S, et al.
Indian Pediatr
. 2024 Jan;
61(1):39-44.
PMID: 38183250
Objective: To describe the clinical pattern of childhood and adolescent cancers across India using hospital-based data in the National Cancer Registry Program. Methods: Records of 60720 cancer cases in the...
4.
Marwah H, Tripathi R, Saikia B, Anand P, Arora R
South Asian J Cancer
. 2023 Dec;
12(3):286-289.
PMID: 38047049
Ramandeep Singh Arora Modern-day treatment of childhood cancer is punctuated by the necessary need for intensive care. This study was performed to understand the intensive care unit (ICU) admission rates...
5.
Israels T, Arora R, Sung L
Pediatr Blood Cancer
. 2023 Sep;
70(12):e30686.
PMID: 37728943
No abstract available.
6.
Nath A, Mathur P, Sudarshan K, Rajput G, Mascarenhas L, Arora R, et al.
Lancet Reg Health Southeast Asia
. 2023 Sep;
16:100235.
PMID: 37694177
Background: Childhood cancers are emerging as an essential concern in India where there is lack of a specific programme component or policy to address childhood cancer control. There is limited...
7.
Li C, Kurkure P, Arora R, Chen B, Kirgizov K, Okamoto Y, et al.
JCO Glob Oncol
. 2023 Sep;
9:e2300153.
PMID: 37656946
In Asia, a few countries have a long and established history of collaborative clinical trials successfully formed national children's cancer study groups, but many still do not have such groups....
8.
Banwait D, Arora P, Mahajan A, Dinand V, Jain S, Kalra M, et al.
Pediatr Hematol Oncol
. 2023 Jun;
41(2):163-168.
PMID: 37264813
No abstract available.
9.
Ferrara G, Aguina M, Mirochnick E, Wiphatphumiprates P, Moreira D, Sniderman E, et al.
Cancer Med
. 2023 Apr;
12(11):12813-12826.
PMID: 37081718
Background: The COVID-19 pandemic altered healthcare systems globally, causing delays in care delivery and increased anxiety among patients and families. This study examined how hospital stakeholders and clinicians perceived the...
10.
Arora R, Kumari R, Adhana A, Tripathi R, Sachdev M, Jain P
Indian Pediatr
. 2023 Feb;
60(7):531-536.
PMID: 36814122
Objective: Using data from a hospital-based cancer registry (HBCR) in the private sector in Northern India, we provide overall survival (OS) and event-free survival (EFS) for childhood cancer patients. Methods:...